| Q50613316 | A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. |
| Q36325762 | Adipose Tissue: A Metabolic Regulator. Potential Implications for the Metabolic Outcome of Subjects Born Small for Gestational Age (SGA) |
| Q37466693 | Advances in molecular imaging of pancreatic beta cells |
| Q37141727 | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus |
| Q33889791 | Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus |
| Q27690875 | Defect of insulin signal in peripheral tissues: Important role of ceramide |
| Q35103998 | Diabetes: mellitus or lipidus? |
| Q36635727 | Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo |
| Q71882554 | Effect of lipid oxidation on the regulation of glucose utilization in obese patients |
| Q54194095 | Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. |
| Q71293202 | Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients |
| Q42498139 | Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance |
| Q68235530 | Heterogeneous glycaemic and insulinaemic responses to oral glucose in non-diabetic men: interactions between duration of obesity, body fat distribution and family history of diabetes mellitus |
| Q28319139 | Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus |
| Q34243161 | Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake |
| Q28748492 | Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting |
| Q40814275 | Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus |
| Q35598180 | Metabolomics specificity of tuberculosis plasma revealed by (1)H NMR spectroscopy |
| Q28469240 | Network-based analysis of affected biological processes in type 2 diabetes models |
| Q35787142 | Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview |
| Q35153950 | Pathophysiology of diabetes. A review of selected recent developments and their impact on treatment |
| Q28360761 | Screening for diabetes in pregnancy |
| Q40389350 | The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity |
| Q47265442 | Weight gain and insulin resistance during nicotine replacement therapy. |